Kohlpharma

Kohlpharma, established in 1979 by Edwin Kohl as a single-person enterprise, has evolved into a significant player in the pharmaceutical distribution sector. Initially founded in Perl, Germany, the company's primary business model involves sourcing original brand pharmaceuticals from EU-licensed wholesalers and importing them into Germany. This strategic approach allows Kohlpharma to acquire products from well-known pharmaceutical manufacturers at competitive prices, serving a critical role in the supply chain. The company operates within the retail and drug stores & pharmacies industries, focusing on B2B and B2C markets.

With a history spanning over four decades, Kohlpharma has grown substantially, now employing a workforce of over 700 individuals. This expansion has led to a presence across multiple locations, with the company operating two distinct sites. The operational footprint is anchored in Germany, with its headquarters located in Merzig, Saarland. The company's growth trajectory is supported by its dedicated team, and for further insight into their organizational structure and personnel, one can Meet Kohlpharma's team.

Kohlpharma generates substantial revenue, reporting $41.5M. The company's market strategy involves leveraging its established network and efficient import operations to maintain a competitive edge. Key hashtags associated with Kohlpharma include #germany, #eu, #europe, #b2b, #b2c, and #founded_1979, indicating its geographic focus and business orientation. While specific funding rounds are not detailed, its consistent operation since 1979 and current revenue suggest a stable financial standing within its industry niche. The company's product sourcing strategy emphasizes adherence to EU regulations and quality standards for imported pharmaceuticals.